From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
October 21, 2019
Philadelphia, PA, October 21, 2019– IntegriChain, a leading life sciences commercial data and analytics company that helps patients start therapy faster and stay on therapy longer, today announced that its annual Access Insights Conference (formerly the IntegriChain User Conference) broke attendance records with more than 190 participants, including seven ecosystem partners and sponsors and more than 25 industry speakers. The three-day conference, beginning today in Atlanta/Buckhead, attracts bio/pharma brand and access teams, including those focused on Contracts & Pricing, Gross-to-Net, Finance, Patient Services, Field Reimbursement, Data Management & Analytics, Trade & Channel, and Commercial Operations from leading and emerging manufacturers.
“We are excited to evolve our Access Insights Conference to deliver even more thought leadership, benchmark data, and industry insights to such a wide audience of bio/pharma executives and professionals – from traditional Big Pharma to emerging biotechs and cell and gene therapy pioneers,” said Kevin Leininger, Co-Founder and CEO of IntegriChain. “Our goal is to help manufacturers develop and execute commercialization and access strategies based on the actionable data and the leading-edge data science we deliver. We will demonstrate how to capitalize on the power of data refining, AI/ML innovation, automation, and scheduled reporting, enabling market access and commercialization teams to scale as they rapidly grow and mature.”
“We thank all our customers for joining us this week in Atlanta and for forging a deep and meaningful partnership to help patients start and stay on therapy,” said Co-Founder and EVP of IntegriChain, Josh Halpern. “We also thank our sponsors and ecosystem partners for supporting our conference and for delivering an expanded set of access insights to our industry attendees.”
The Access Insights Conference kicks off today with the Executive Summit, delivering thought leadership, benchmark data, and high-value industry panels focused on strategies to drive pharmaceutical commercialization and access. Beginning on Day 2, more industry speakers and subject matter experts take the podium for dozens of topic track sessions focused on utilizing data and analytics to overcome commercialization and access challenges. The conference also includes a pre-conference event, the Revenue Analytics Collaborative Summit, for those in Pricing & Contracting, Rebate & Chargeback Management, GTN, and Trade & Channel for roundtable discussions, benchmarking, and networking.
Conference Ecosystem Partners The Access Insights Conference is sponsored by Mirador Analytics, PwC, TrialCard, and Two Labs Pharma Services and is supported by the following IntegriChain ecosystem partners: CareMetx, Crossix, and EVERSANA.
About IntegriChain IntegriChain is a life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence. Our mission is to help all stakeholders in pharmaceutical access save as many patient days of therapy as possible. Our data-science-driven ICyte Platform and solutions uniquely focus on access challenges after the patient and provider commit to therapy. More than 165 life science manufacturers rely on insights delivered from IntegriChain’s data, analytics, and managed services to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, and Pune, India. For more information, visit www.integrichain.com and our blog, or follow us on Twitter @IntegriChain and LinkedIn.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
